What is Quillivant XR 25 mg?
Quillivant XR is an extended-release formulation of methylphenidate, a stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adults (age range depends on the specific prescribing information). The “25 mg” strength refers to the amount of methylphenidate in each dose of the extended-release product.
How is Quillivant XR 25 mg taken?
Quillivant XR is taken once daily because it is designed to release medication over the day. The exact dose and timing depend on the prescriber’s titration and the patient’s response. The product’s labeling also includes instructions on how to prepare and measure the dose (commonly relevant because Quillivant XR is a liquid).
What does “25 mg” mean for duration and effect?
Because Quillivant XR is extended-release, the goal is a gradual release after dosing, rather than an immediate “peak” effect like an immediate-release tablet. Patients typically get symptom control that lasts through school/work hours, but individual results vary.
Is Quillivant XR 25 mg a brand or a generic?
Quillivant XR is a brand-name medication. Whether a lower-cost generic is available (and in what strengths) depends on current approvals and availability.
What side effects are people likely to ask about?
As with other methylphenidate products, common concerns include:
- reduced appetite or weight loss
- trouble sleeping
- increased heart rate or blood pressure
- stomach pain, headache, or anxiety/jitteriness
Serious risks (such as cardiovascular events or worsening psychiatric symptoms) are addressed in prescribing information and typically require monitoring.
Does DrugPatentWatch track Quillivant XR patents?
DrugPatentWatch can be a useful place to check patent or exclusivity status for ADHD products and related formulations. If you share whether you mean methylphenidate ER liquid (Quillivant XR) specifically and the country you’re asking about (US vs elsewhere), I can point you to the most relevant page.
Sources:
1. DrugPatentWatch